0.00Open0.00Pre Close0 Volume0 Open Interest11.00Strike Price0.00Turnover0.00%IV66.17%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.27Leverage Ratio--Theta--Rho--Eff Leverage--Vega
IonQ Inc Stock Discussion
Back to 30
Renovaro focuses on AI-driven healthcare innovation, particularly in early cancer detection and immunotherapy. Their flagship product, RenovaroCube, uses AI for diagnostics. The company has also acquired GEDi Cube and formed partnerships with institutions like Amsterdam UMC Cancer Center. Recent restructuring includes appointing David Weinstein as CEO .
2. $Rigetti Computing (RGTI.US)$Rigetti Co...
Day Trader and Shortee know this stock are the attracting attention so they just want a quick buck but eventual winner is LONG
ionq.com/news/new-york-…
No comment yet